Brief: Galectin Therapeutics Inc - QTRLY Loss Per Share $0.17
16/05/2022 13:25
May 16 (Reuters) - Galectin Therapeutics Inc GALT.O :
* GALECTIN THERAPEUTICS INC - QTRLY LOSS PER SHARE $0.17
* GALECTIN THERAPEUTICS- SEES HAS SUFFICIENT CASH TO FUND
CURRENTLY PLANNED OPERATIONS, RESEARCH, DEVELOPMENT ACTIVITIES
THROUGH AT LEAST MAY 16, 2023
Further company coverage: GALT.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Galectin Therapeutics
See all newsGalectin Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary
Brief: Galectin Therapeutics Reports June 30, 2026 Financial Results
Galectin Therapeutics Q2 loss widens
Galectin Therapeutics Inc expected to post a loss of 9 cents a share - Earnings Preview
Galectin Therapeutics rises as FDA clears path for late-stage liver drug study